Literature DB >> 9660790

The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells.

H Tang1, D M Kerins, Q Hao, T Inagami, D E Vaughan.   

Abstract

Urokinase-type plasminogen activator (uPA) binds to cells via a specific glycosylphosphatidylinositol-anchored receptor. Although occupancy of the uPA receptor (uPAR) has been shown to alter cellular function and to induce gene expression, the signaling mechanism has not been characterized. Urokinase induced an increase in the tyrosine phosphorylation of multiple proteins in bovine aortic endothelial cells. In contrast, low molecular weight uPA did not induce this response. Analysis by immunoblotting demonstrated tyrosine phosphorylation of focal adhesion kinase (FAK), the focal adhesion-associated proteins paxillin and p130(cas), and mitogen-activated protein kinase (MAPK) following the occupancy of the uPAR by uPA. Treatment of cells with phosphatidylinositol-specific phospholipase C, which cleaves glycosylphosphatidylinositol-linked proteins from the cell surface, blocked the uPA-induced tyrosine phosphorylation of FAK, indicating the requirement of an intact uPAR on the cell surface. The uPA-induced activation of MAPK was completely inhibited by genistein, but not by 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3, 4-d]pyrimidine, a specific inhibitor of Src family kinases. Thus, this study demonstrates a novel role for the uPAR in endothelial cell signal transduction that involves the activation of FAK and MAPK, which are mediated by the receptor-binding domain of uPA. This may have important implications for the mechanism through which uPA influences cell migration and differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660790     DOI: 10.1074/jbc.273.29.18268

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Isolation and characterization of cell lines with reduced urokinase binding.

Authors:  H K Lau; J M Teitel; M Kim
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Inhibition of podocyte FAK protects against proteinuria and foot process effacement.

Authors:  Hong Ma; Akashi Togawa; Keita Soda; Junhui Zhang; Sik Lee; Ming Ma; Zhiheng Yu; Thomas Ardito; Jan Czyzyk; Lonnette Diggs; Dominique Joly; Shinji Hatakeyama; Eiji Kawahara; Lawrence Holzman; Jun Lin Guan; Shuta Ishibe
Journal:  J Am Soc Nephrol       Date:  2010-06-03       Impact factor: 10.121

3.  Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth.

Authors:  Christopher S Gondi; Sajani S Lakka; Dzung H Dinh; William C Olivero; Meena Gujrati; Jasti S Rao
Journal:  Neuron Glia Biol       Date:  2004-05

4.  The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC12 pheochromocytoma cells and is required for NGF-driven differentiation.

Authors:  R Farias-Eisner; L Vician; A Silver; S Reddy; S A Rabbani; H R Herschman
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

Review 5.  Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease.

Authors:  Victoria A Ploplis
Journal:  Curr Drug Targets       Date:  2011-11       Impact factor: 3.465

6.  Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence.

Authors:  F Chiaradonna; L Fontana; C Iavarone; M V Carriero; G Scholz; M V Barone; M P Stoppelli
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

7.  Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices.

Authors:  M E Kroon; P Koolwijk; H van Goor; U H Weidle; A Collen; G van der Pluijm; V W van Hinsbergh
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

8.  The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells.

Authors:  Veera D'mello; Sukhwinder Singh; Yi Wu; Raymond B Birge
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

9.  Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.

Authors:  Gretchen A Larusch; Alona Merkulova; Fakhri Mahdi; Zia Shariat-Madar; Robert G Sitrin; Douglas B Cines; Alvin H Schmaier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-24       Impact factor: 4.733

10.  The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization.

Authors:  Yuchuan Liu; Dian J Cao; Irma M Sainz; Yan-Lin Guo; Robert W Colman
Journal:  Am J Physiol Cell Physiol       Date:  2008-05-21       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.